Businesses in West Dunbartonshire are being urged to seize the opportunity presented by the £160 million Glasgow City Region Investment Zone, as the initiative takes a significant stride forward with the launch of an open call for project funding bids.
Edinburgh-based Intelligent Growth Solutions (IGS) has successfully raised £22.5 million in a Series C funding round to support significant global expansion as the business deploys its vertical farming technology to customers worldwide.
N4 Partners has recently concluded an additional seven-figure investment in NeuroClin, an innovative neurological research organisation based at the Eurocentral business hub.
InnoScot Health is urging Scottish innovation and science collaborators to take advantage of a £7.5 million pot of grant funding available from Innovate UK.
The Industrial Biotechnology Innovation Centre (IBioIC) has been awarded long-term investment from the Scottish Funding Council (SFC), securing its position at the forefront of Scotland’s emerging bioeconomy.
Edinburgh-based cancer therapeutics development specialist Cumulus Oncology has successfully secured a £9 million funding package, including a significant contribution of £6m from the Scottish National Investment Bank.
The Sustainable Aquaculture Innovation Centre (SAIC) has announced it will support further research into fish health and wellbeing initiatives in 2024, with seven successful projects set to benefit from its most recent funding call.
Kelso Pharma, the growing Edinburgh-based specialty pharma business, has concluded two new collaboration agreements with pharmaceuticals companies, PharmaPath and Valpharma.
Major expansion works have been completed at a long-established Glasgow dental clinic in a bid to meet the rising demand for dental services in the area.
University of the West of Scotland’s spinout company AlbaSense has secured £339,269 in funding from the Digital Dairy Chain’s Collaborative R&D Funding Competition, awarded by Innovate UK.
Edinburgh-headquartered pharmaceutical firm Kelso Pharma has expanded its portfolio with the acquisition of two UK approved dermatological products, marking its debut in the treatment of actinic keratoses and plaque psoriasis.
Two professional services firms have signalled their support for female founders by providing funding for their families to travel to one of the world’s biggest tech conferences.
Researchers at the University of Dundee’s Schools of Medicine and Life Sciences have received $4.4 million from the Bill & Melinda Gates Foundation to help discover potential contraceptives that work by affecting the sperm once they have entered the female reproductive system.